Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

North America Ophthalmic Drug Delivery System Market


North America Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1641003 | Industry: Healthcare and Social Assistance | Published On: 44742


North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 20 tables and 53 figures, this 116-page report “North America Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pre-filled Syringes
• Multidose Eyedroppers
• Squeeze Dispensers
• Mist Sprayers
• Contact Lenses
• Ocular Inserts
• Intraocular Implants
• Punctal Plugs
• Other Products

Based on Dosage Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solutions
• Gels
• Ointments
• Suspensions
• Emulsions
• Liposomes & Nanoparticles

By Disease, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Glaucoma
• Diabetic Retinopathy
• Cataract
• Dry Eye Syndrome
• Macular Degeneration
• Diabetic Macular Edema
• Refractive Issues
• Other Diseases

By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Other Settings

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aero Pump GmbH
Allergan plc.
AptarGroup, Inc.
Becton, Dickinson and Company
Biocorp
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer AG
Jotteq Inc.
Kedalion Therapeutics, Inc.
Mati Therapeutics, Inc.
Nemera
Nipro Corporation
Ocular Therapeutix, Inc.
Ocumedic, Inc.
Owen Mumford
Re-Vana Therapeutics
Silgan Holdings Inc.
Terumo Corporation
Valeant Pharmaceuticals International Inc. (Bausch Health Company)
West Pharmaceutical Services, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction 7
1.1  Industry  Definition  and  Research  Scope 7
1.1.1  Industry  Definition 7
1.1.2  Research  Scope 8
1.2  Research  Methodology 11
1.2.1  Overview  of  Market  Research  Methodology 11
1.2.2  Market  Assumption 12
1.2.3  Secondary  Data 12
1.2.4  Primary  Data 12
1.2.5  Data  Filtration  and  Model  Design 13
1.2.6  Market  Size/Share  Estimation 14
1.2.7  Research  Limitations 15
1.3  Executive  Summary 16
2  Market  Overview  and  Dynamics 19
2.1  Market  Size  and  Forecast 19
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 23
2.2  Major  Growth  Drivers 25
2.3  Market  Restraints  and  Challenges 29
2.4  Emerging  Opportunities  and  Market  Trends 32
2.5  Porter’s  Fiver  Forces  Analysis 36
3  Segmentation  of  North  America  Market  by  Product 40
3.1  Market  Overview  by  Product 40
3.2  Pre-filled  Syringes 42
3.3  Multidose  Eyedroppers 43
3.4  Squeeze  Dispensers 44
3.5  Mist  Sprayers 45
3.6  Contact  Lenses 46
3.7  Ocular  Inserts 47
3.8  Intraocular  Implants 48
3.9  Punctal  Plugs 49
3.10  Other  Products 50
4  Segmentation  of  North  America  Market  by  Dosage  Form 51
4.1  Market  Overview  by  Dosage  Form 51
4.2  Solutions 53
4.3  Gels 54
4.4  Ointments 55
4.5  Suspensions 56
4.6  Emulsions 57
4.7  Liposomes  &  Nanoparticles 58
5  Segmentation  of  North  America  Market  by  Disease 59
5.1  Market  Overview  by  Disease 59
5.2  Glaucoma 61
5.3  Diabetic  Retinopathy 62
5.4  Cataract 63
5.5  Dry  Eye  Syndrome 64
5.6  Macular  Degeneration 65
5.7  Diabetic  Macular  Edema 66
5.8  Refractive  Issues 67
5.9  Other  Diseases 68
6  Segmentation  of  North  America  Market  by  Setting 69
6.1  Market  Overview  by  Setting 69
6.2  Hospitals 71
6.3  Clinics 72
6.4  Homecare  Settings 73
6.5  Ambulatory  Surgical  Centers  (ASCs) 74
6.6  Other  Settings 75
7  North  America  Market  2021-2031  by  Country 76
7.1  Overview  of  North  America  Market 76
7.2  U.S. 79
7.3  Canada 83
7.4  Mexico 86
8  Competitive  Landscape 89
8.1  Overview  of  Key  Vendors 89
8.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 92
8.3  Company  Profiles 93
Aero  Pump  GmbH 93
Allergan  plc. 95
AptarGroup,  Inc. 96
Becton,  Dickinson  and  Company 97
Biocorp 98
Clearside  Biomedical,  Inc. 99
EyePoint  Pharmaceuticals,  Inc. 100
Gaplast  GmbH 101
Gerresheimer  AG 102
Jotteq  Inc. 103
Kedalion  Therapeutics,  Inc. 104
Mati  Therapeutics,  Inc. 105
Nemera 106
Nipro  Corporation 107
Ocular  Therapeutix,  Inc. 108
Ocumedic,  Inc. 109
Owen  Mumford 110
Re-Vana  Therapeutics 111
Silgan  Holdings  Inc. 112
Terumo  Corporation 113
Valeant  Pharmaceuticals  International  Inc.  (Bausch  Health  Company) 114
West  Pharmaceutical  Services,  Inc. 115
RELATED  REPORTS 116
List of Tables:

Table 1. Snapshot of North America Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Main Product Trends and Market Opportunities in North America Ophthalmic Drug Delivery System Market 32
Table 4. North America Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 40
Table 5. North America Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 51
Table 6. North America Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 59
Table 7. North America Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 69
Table 8. North America Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 77
Table 9. U.S. Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 81
Table 10. U.S. Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 81
Table 11. U.S. Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 82
Table 12. Canada Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 84
Table 13. Canada Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 84
Table 14. Canada Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 85
Table 15. Mexico Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 87
Table 16. Mexico Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 87
Table 17. Mexico Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 88
Table 18. Aero Pump GmbH: Company Snapshot 93
Table 19. Aero Pump GmbH: Business Segmentation 94
Table 20. Aero Pump GmbH: Product Portfolio 94
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT